-I David Goldman Researcher Activity Profile

Research Author Detailed Information 

I David Goldman Publication Rate By Year

I David Goldman has published 1 paper(s) in 2006, 6 paper(s) in 2007, 2 paper(s) in 2008, for a total of 9 research publications in total.

I David Id Goldman Author Information

LAST NAME: goldman

FIRST NAME: I David

INITIALS: id

AFFILIATION:

Papers

I David Goldman's Publication Record

1. The effect of a novel transition state inhibitor of methylthioadenosine phosphorylase on pemetrexed activity. Year Published: 2006
Department of Medicine and Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York 10461, USA.
2. Schedule-dependent cytotoxic synergism of pemetrexed and erlotinib in human non-small cell lung cancer cells. Year Published: 2007
Department of Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York 10461, USA. tli@montefiore.org
3. Commentary: a case for minimizing folate supplementation in clinical regimens with pemetrexed based on the marked sensitivity of the drug to folate availability. Year Published: 2007
Department of Medicine, The Albert Einstein College of Medicine Cancer Center, Bronx, NY 10461, USA.
4. The spectrum of mutations in the PCFT gene, coding for an intestinal folate transporter, that are the basis for hereditary folate malabsorption. Year Published: 2007
Departments of Medicine, Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
5. Rodent intestinal folate transporters (SLC46A1): secondary structure, functional properties, and response to dietary folate restriction. Year Published: 2007
Department of Medicine, Albert Einstein College of Medicine, Bronx, New York 10461, USA.
6. Rodent intestinal folate transporters (SLC46A1): secondary structure, functional properties, and response to dietary folate restriction. Year Published: 2007
Department of Medicine, Albert Einstein College of Medicine, Bronx, New York 10461, USA.
7. Caffeine markedly sensitizes human mesothelioma cell lines to pemetrexed. Year Published: 2008
Departments of Medicine and Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY, 10461, USA.
8. Commentary: a case for minimizing folate supplementation in clinical regimens with pemetrexed based on the marked sensitivity of the drug to folate availability. Year Published: 2007
Department of Medicine, The Albert Einstein College of Medicine Cancer Center, Bronx, NY 10461, USA.
9. Characterization of folate uptake by choroid plexus epithelial cells in a rat primary culture model. Year Published: 2008
Department of Pediatrics, Cancer Institute of New Jersey, Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.